Recent advances have been made for the isolation of TEV in melanoma, when antibodies against melanoma antigen chondroitin sulfate proteoglycan (CSPG)4 were used for on-beads immunocapturing of melanoma-derived EV [47]. Here, CSPG4 is linked to melanoma.